Source:http://linkedlifedata.com/resource/pubmed/id/18752720
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2008-11-5
|
pubmed:abstractText |
Several clinical studies on major depressive disorder (MDD) have shown that blood brain-derived neurotrophic factor (BDNF) - a factor used to index neuroplasticity - is associated with depression response; however, the results are mixed. The purpose of our study was to evaluate whether BDNF levels are correlated with improvement of depression. We performed a systematic review and meta-analysis of the literature, searching Medline, Cochrane Central, SciELO databases and reference lists from retrieved articles for clinical studies comparing mean BDNF blood levels in depressed patients pre- and post-antidepressant treatments or comparing depressed patients with healthy controls. Two reviewers independently searched for eligible studies and extracted outcome data using a structured form previously elaborated. Twenty articles, including 1504 subjects, met our inclusion criteria. The results showed that BDNF levels increased significantly after antidepressant treatment (effect size 0.62, 95% CI 0.36-0.88, random effects model). In addition, there was a significant correlation between changes in BDNF level and depression scores changes (p=0.02). Moreover, the results were robust according to the sensitivity analysis and Begg's funnel plot results did not suggest publication bias. Finally, there was a difference between pre-treatment patients and healthy controls (effect size 0.91, 95% CI 0.70-1.11) and a small but significant difference between treated patients and healthy controls (effect size 0.34, 95% CI 0.02-0.66). Our results show that BDNF levels are associated with clinical changes in depression; supporting the notion that depression improvement is associated with neuroplastic changes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1461-1457
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1169-80
|
pubmed:meshHeading |
pubmed-meshheading:18752720-Adolescent,
pubmed-meshheading:18752720-Adult,
pubmed-meshheading:18752720-Aged,
pubmed-meshheading:18752720-Brain-Derived Neurotrophic Factor,
pubmed-meshheading:18752720-Data Interpretation, Statistical,
pubmed-meshheading:18752720-Depressive Disorder, Major,
pubmed-meshheading:18752720-Female,
pubmed-meshheading:18752720-Humans,
pubmed-meshheading:18752720-Male,
pubmed-meshheading:18752720-Middle Aged,
pubmed-meshheading:18752720-Neuronal Plasticity,
pubmed-meshheading:18752720-Quality Control,
pubmed-meshheading:18752720-Young Adult
|
pubmed:year |
2008
|
pubmed:articleTitle |
A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression.
|
pubmed:affiliation |
Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
|
pubmed:publicationType |
Journal Article,
Review
|